Drug Profile
Research programme: protein-based companion diagnostics for autoimmune disorders - Protagen/QIAGEN
Latest Information Update: 28 Dec 2018
Price :
$50
*
At a glance
- Originator Protagen AG; QIAGEN
- Class Diagnostic agents; Proteins
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for research development in Autoimmune-disorders(Diagnosis) in Germany
- 18 Nov 2014 Early research in Autoimmune disorders (Diagnosis) in Germany (unspecified route)